John Lazoritz, DPM
Foot & Ankle Surgery · Sterling Heights, MINPI 1124446166
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (32.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 38.4% of the total. Reporting peaked in 2024 at $4,447 and has fallen 86.7% since, to $591 in 2025.
Across 152 payments — averaging $106.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Arthrex$4K
- Integra Lifesciences Corporation$3K
- Smith+Nephew$825
- Conetic Solutions, Inc.$758
- RSW Medical Company, Inc.$742
- plus $511 from 11 others
What the payments were for
- Travel & lodging$4,14826%
- Food & beverage$5,23532%
- Education$3,72623%
- Other$3,00919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 55 | $6,183 |
| Arthrex | 9 | $3,938 |
| Integra Lifesciences Corporation | 13 | $3,162 |
| Smith+Nephew | 41 | $825 |
| Conetic Solutions, Inc. | 6 | $758 |
| RSW Medical Company, Inc. | 6 | $742 |
| Organogenesis Inc. | 4 | $218 |
| Amgen(2 entities) | 7 | $95 |
| Averitas Pharma Inc. | 3 | $60 |
| Misonix Inc | 1 | $27 |
| Osiris Therapeutics Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $16 |
| Insulet Corporation | 1 | $16 |
| Seagen Inc. | 1 | $15 |
| Morphosys, US Inc. | 1 | $14 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$2,349
- FIXOS$1,159
- STAR$1,006
- T2$1,006
- AXSOS$1,006
- AUGMENT INJECTABLE$924
- ORTHOLOC 2 LAPIFUSE$917
- PROstep$912
- ORTHOLOC 3DI$890
- PROPHECY$845
- INBONE$581
- INVISION$581
- ACell$565
- VARIAX$452
- PROSTEP MICA$296
- OMEGA$173
- VALOR$153
- CITREFIX$141
- Affinity$125
- ACTISHIELD CF$106
How this compares
$16,119 in reported general payments places this provider in the 85th percentile of 384 foot & ankle surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 12 | $207 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $105 |
| Meloxicam | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Sterling Heights
- Arnold WolfSterling Heights$13K
- John AndersonGrand Rapids$1.3M
- Brian LoderClinton Township$854K
- Karl DunnClinton Twp$434K
- Anthony LalamaMacomb$421K
- Christopher ZingasSaint Clair Shores$227K
- John MaskillGrand Rapids$202K
- Michael SwordsLansing$189K
- Gregory SheremetaTroy$87K
- Jason WesloskyClinton Township$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.